Silencing Immune Dialogue in Multiple Sclerosis
- PMID: 38354146
- PMCID: PMC10959047
- DOI: 10.1056/NEJMe2314434
Silencing Immune Dialogue in Multiple Sclerosis
References
-
- Vermersch P, Granziera C, Mao-Draayer Y, et al. Inhibition of CD40L with Frexalimab in Multiple Sclerosis. N Engl J Med 2024. - PubMed
-
- Li R, Rezk A, Miyazaki Y, et al. Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy. Sci Transl Med 2015;7:310ra166. - PubMed
-
- Kappos L, Hartung HP, Freedman MS, et al. Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial. Lancet Neurol 2014;13:353–63. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical